Clickotine is a comprehensive smoking cessation solution that is designed to be a one-stop shop for partners and end users. Clickotine uses Key Mechanisms of Action (MOAs) to engage community members throughout a personalized quit journey to help them quit for good. All MOAs are validated in clinical studies published in peer-reviewed medical journals.
A robust clinical study yielded the following results:
In a 416-participant clinical study, 188 (45.2%) of the participants had stopped smoking at the end of the study (no cigarettes, not even a puff, for at least 7 days). On average, participants opened the Clickotine app 100.6 times and performed an additional 214.4 interactions with the program MOAs over the 8-week study period.
All of Click's programs use Click Digital Care, an AI-augmented patient success program that wraps-around each Click digital therapeutic to help patients succeed with the therapy.
Comments